Clinical Trial Update: Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Yttrium-90 radioembolization for metastatic liver cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Yttrium-90 radioembolization (yttrium-90 microspheres)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Liver Carcinoma, Stage IV Liver Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING